We report for the first time the design and synthesis of a novel cyclotide able to activate the unique receptor of angiotensin (1-7) (AT1-7), the MAS1 receptor. This was accomplished by grafting an AT1-7 peptide analog onto loop 6 of cyclotide MCoTI-I using isopeptide bonds to preserve the α-amino and C-terminal carboxylate groups of AT1-7, which are required for activity. The resulting cyclotide construct was able to adopt a cyclotide-like conformation and showed similar activity to that of AT1-7. This cyclotide also showed high stability in human serum thereby providing a promising lead compound for the design of a novel type of peptide-based in the treatment of cancer and myocardial infarction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795166PMC
http://dx.doi.org/10.3390/molecules21020152DOI Listing

Publication Analysis

Top Keywords

cyclotide
5
design mcoti-based
4
mcoti-based cyclotide
4
cyclotide angiotensin
4
angiotensin 1-7-like
4
1-7-like activity
4
activity report
4
report time
4
time design
4
design synthesis
4

Similar Publications

Background: is the bacterium responsible for gonorrhoea, one of the most common sexually transmitted infections (STIs) globally. In 2020, the World Health Organization (WHO) estimated 82.4 million new cases of infections.

View Article and Find Full Text PDF
Article Synopsis
  • Cyclotides are stable cyclic peptides with potential to protect neurons in neurological disorders by modifying their structure for better delivery.
  • The study involved enhancing the cyclotide MCoTI-II with polyarginines and inserting an NMDA receptor inhibitor sequence, which improved neuronal uptake and prevented cell death from excitotoxicity.
  • In tests, the modified cyclotide (c5R-NR2B9c) not only protected primary neurons but also increased survival and reduced seizure severity in a mouse model, indicating its potential as a therapeutic strategy.
View Article and Find Full Text PDF

An efficient and easily obtainable butelase variant for chemoenzymatic ligation and modification of peptides and proteins.

Microb Cell Fact

November 2024

Department of Chemical Biology, Faculty of Biotechnology, University of Wroclaw, Joliot-Curie 14a, Wrocław, 50-383, Poland.

The expanding field of site-specific ligation of proteins and peptides has catalyzed the development of novel methods that enhance molecular modification. Among these methods, enzymatic strategies have emerged as dominant due to their specificity and efficiency in modifying proteins under mild conditions. Asparaginyl endopeptidase is a group of cyclotide-producing cysteine proteases from plants.

View Article and Find Full Text PDF

Integrative transcriptome and mass spectrometry analysis reveals novel cyclotides with antimicrobial and cytotoxic activities from Viola arcuata.

Plant Physiol Biochem

November 2024

Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China; Key Laboratory of Tropical Biological Resources of Ministry of Education, Hainan University, Haikou, China.

View Article and Find Full Text PDF

Peptide-based medications hold immense potential in addressing a wide range of human disorders and discomforts. However, their widespread utilization encounters two major challenges: preservation and production efficiency. Cyclotides, a class of ribosomally synthesized and post-translationally modified peptides (RiPPs), exhibit unique characteristics, such as a cyclic backbone and cystine knot, enhancing their stability and contributing to a wide range of pharmacological properties exhibited by these compounds.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!